Follow
Dorie Apollonio
Dorie Apollonio
Professor, UCSF
Verified email at ucsf.edu - Homepage
Title
Cited by
Cited by
Year
Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill
DE Apollonio, RE Malone
Tobacco control 14 (6), 409-415, 2005
1582005
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders
D Apollonio, R Philipps, L Bero
Cochrane database of systematic reviews, 2016
1262016
The creation of industry front groups: the tobacco industry and “get government off our back”
DE Apollonio, LA Bero
American Journal of Public Health 97 (3), 419-427, 2007
1182007
Who gave soft money? The effect of interest group resources on political contributions
DE Apollonio, RJL Raja
The Journal of Politics 66 (4), 1134-1154, 2004
722004
Turning negative into positive: public health mass media campaigns and negative advertising
DE Apollonio, RE Malone
Health education research 24 (3), 483-495, 2009
682009
Access and lobbying: Looking beyond the corruption paradigm
D Apollonio, BE Cain, L Drutman
Hastings Const. LQ 36, 13, 2008
552008
The “We Card” program: tobacco industry “youth smoking prevention” as industry self-preservation
DE Apollonio, RE Malone
American journal of public health 100 (7), 1188-1201, 2010
532010
Minimum ages of legal access for tobacco in the United States from 1863 to 2015
DE Apollonio, SA Glantz
American journal of public health 106 (7), 1200-1207, 2016
522016
Term limits, campaign contributions, and the distribution of power in state legislatures
DE Apollonio, RJ La Raja
Legislative Studies Quarterly 31 (2), 259-281, 2006
442006
Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: an historical analysis of internal documents
CE Kearns, D Apollonio, SA Glantz
PLoS biology 15 (11), e2003460, 2017
422017
Pharmacy students can improve access to quality medicines information by editing Wikipedia articles
DE Apollonio, K Broyde, A Azzam, M De Guia, J Heilman, T Brock
BMC Medical Education 18, 1-8, 2018
392018
Interventions to reduce tobacco use in people experiencing homelessness
M Vijayaraghavan, H Elser, K Frazer, N Lindson, D Apollonio
Cochrane database of systematic reviews, 2020
362020
Tobacco industry promotions and pricing after Tax increases: an analysis of internal industry documents
DE Apollonio, SA Glantz
Nicotine and Tobacco Research 22 (6), 967-974, 2020
342020
Tobacco industry research on nicotine replacement therapy:“If anyone is going to take away our business it should be us”
D Apollonio, SA Glantz
American journal of public health 107 (10), 1636-1642, 2017
342017
Associations between smoking trajectories, smoke-free laws and cigarette taxes in a longitudinal sample of youth and young adults
DE Apollonio, LM Dutra, SA Glantz
PloS one 16 (2), e0246321, 2021
322021
Interpretation and use of evidence in state policymaking: a qualitative analysis
DE Apollonio, LA Bero
BMJ open 7 (2), e012738, 2017
232017
Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers
D Krauth, DE Apollonio
Tobacco induced diseases 13, 1-6, 2015
232015
Evidence and argument in policymaking: development of workplace smoking legislation
DE Apollonio, LA Bero
BMC Public Health 9, 1-10, 2009
212009
Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic
W Roth, M Tam, C Bi, J Kim, J Lewis, R Ho, DE Apollonio
Clinical Toxicology 60 (5), 632-638, 2022
192022
An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies
R Bellman, S Mohebbi, N Nobahar, J Parizher, DE Apollonio
Journal of the American Pharmacists Association 62 (1), 370-377. e3, 2022
172022
The system can't perform the operation now. Try again later.
Articles 1–20